Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Cells|January 20, 2021
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant ChemotherapyHelge Taubert, Markus Eckstein, Elena Epple, et al.
Cells|August 7, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer PatientsMarkus Eckstein, Verena Lieb, Rudolf Jung, et al.
Plos One|January 29, 2021
Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19Paul Balfanz, Bojan Hartmann, Dirk Müller-Wieland, et al.
Molecular Metabolism|October 27, 2015
TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic miceRobert Stöhr, Ben Arpad Kappel, Daniela Carnevale, et al.
International Journal of Cancer|August 22, 2014
Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutationsCornelia Kraus, Tilman T Rau, Philipp Lux, et al.
International Journal of Cancer|March 11, 2015
The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancerSven Wach, Omar Al-Janabi, Katrin Weigelt, et al.
The Journal of Molecular Diagnostics : JMD|February 23, 2024
Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA SequencingLea D Schlieben, Maria Giulia Carta, Evgeny A Moskalev, et al.
Deutsches Arzteblatt International|June 11, 2020
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDSMichael Dreher, Alexander Kersten, Johannes Bickenbach, et al.
European Journal of Heart Failure|July 15, 2026
Rethinking Tricuspid Valve Regurgitation in Heart Failure - A Pathophysiology-based Holistic Approach for Individualized Patient ManagementKarl-Patrik Kresoja, Lukas Stolz, Antonio Cannata, et al.
Scientific Reports|June 11, 2026
Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patientsRenata Dubrovska, Markus Eckstein, Rudolf Jung, et al.
Pageof 9